Viewing Study NCT03603366


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-21 @ 11:08 AM
Study NCT ID: NCT03603366
Status: COMPLETED
Last Update Posted: 2020-10-05
First Post: 2018-07-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum
Sponsor: Bayer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 20211
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators